Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study
Biomolecules · 07.04.2025 · 15 (4) · 541
DOI: 10.3390/biom15040541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 07.04.2025. Verfasst von Aria Gheeraert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mathematics (LAMA), CNRS, University of Savoie Mont Blanc, 73370 Le Bourget-du-Lac, France. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, SARS-CoV-2, Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Region Occitanie, French Research National Agency (ANR).
Abstract (Originalsprache)
The SARS-CoV-2 Omicron variants show different behavior compared to the previous variants, especially with respect to the Delta variant, which promotes a lower morbidity despite being much more contagious. In this perspective, we performed molecular dynamics (MD) simulations of the different spike RBD/hACE2 complexes corresponding to the WT, Delta and four Omicron variants. Carrying out a comprehensive analysis of residue interactions within and between the two partners allowed us to draw the profile of each variant by using complementary methods (PairInt, hydrophobic potential, contact PCA). PairInt calculations highlighted the residues most involved in electrostatic interactions, which make a strong contribution to the binding with highly stable interactions between spike RBD and hACE2. Apolar contacts made a substantial and complementary contribution in Omicron with the detection of two hydrophobic patches. Contact networks and cross-correlation matrices were able to detect subtle changes at point mutations as the S375F mutation occurring in all Omicron variants, which is likely to confer an advantage in binding stability. This study brings new highlights on the dynamic binding of spike RBD to hACE2, which may explain the final persistence of Omicron over Delta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Mathematics (LAMA), CNRS, University of Savoie Mont Blanc, 73370 Le Bourget-du-Lac, France.
- Dipartimento di Chimica Industriale "Toso Montanari", Università di Bologna, Viale del Risorgimento, 40129 Bologna, Italy.
- LORIA, CNRS, Inria, University of Lorraine, 54506 Vandoeuvre-lès-Nancy, France.
- ENS, CNRS, Laboratoire de Chimie UMR 5182, 69364 Lyon, France.
- Institut de Recherche en Infectiologie de Montpellier (IRIM), CNRS, University of Montpellier, 34293 Montpellier, France.
ORCID-Profile: Yasaman Karami, Isaure Chauvot de Beauchêne, Ivan Rivalta, Bernard Maigret, Laurent Chaloin
Förderung
- Agence Nationale de la Recherche
- Region Occitanie
- French Research National Agency (ANR)
- CNRS
- Federation of European Biochemical Societies
Zitieren
APA
Gheeraert, A., Leroux, V., Mias-Lucquin, D., Karami, Y., Vuillon, L., Chauvot de Beauchêne, I., Devignes, M. D., Rivalta, I., Maigret, B., & Chaloin, L. (2025). Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study. Biomolecules, 15(4), 541. https://doi.org/10.3390/biom15040541
Vancouver
Gheeraert A, Leroux V, Mias-Lucquin D, Karami Y, Vuillon L, Chauvot de Beauchêne I, et al. Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study. Biomolecules. 2025;15(4):541. doi:10.3390/biom15040541
BibTeX
@article{Gheeraert2025,
author = {Gheeraert, Aria and Leroux, Vincent and Mias-Lucquin, Dominique and Karami, Yasaman and Vuillon, Laurent and Chauvot de Beauchêne, Isaure and Devignes, Marie-Dominique and Rivalta, Ivan and Maigret, Bernard and Chaloin, Laurent},
title = {Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {4},
pages = {541},
doi = {10.3390/biom15040541}
}
EUVIMED